acut
otiti
media
aom
common
ill
necessit
medic
therapi
children
younger
year
unit
state
also
one
major
reason
antibiot
prescript
children
mani
countri
evid
date
suggest
aom
may
pure
bacteri
diseas
rather
polymicrobi
diseas
bacteria
respiratori
virus
particip
interact
diseas
pathogenesi
case
viral
upper
respiratori
tract
infect
uri
occur
andor
concurr
aom
also
shown
onethird
children
viral
uri
develop
aom
within
week
onset
use
convent
molecular
diagnost
respiratori
virus
detect
nasopharynx
major
case
middl
ear
fluid
mef
children
present
aom
notabl
tympan
membran
chang
aom
observ
earli
first
day
symptomat
viral
uri
current
evid
suggest
specif
virusbacteri
interact
may
associ
differ
risk
aom
develop
differ
mechan
review
sought
identifi
current
knowledg
regard
interact
pathogenesi
clinic
cours
aom
three
common
bacteri
pathogen
aom
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
colon
nasopharynx
earli
infanc
consid
part
normal
flora
like
nonpathogen
bacteri
flora
colon
nasopharynx
pathogen
bacteria
caus
symptom
chang
nasopharyng
milieu
viral
uri
play
pivot
role
aom
pathogenesi
caus
nasopharyng
inflamm
chang
bacteri
adher
properti
colon
eustachian
tube
et
dysfunct
et
natur
barrier
prevent
influx
colon
bacteria
nasopharynx
middl
ear
caviti
young
children
suscept
aom
immatur
system
immun
also
lack
anatom
immun
et
viral
uri
inflammatori
chang
nasopharynx
et
induc
bacteri
adher
colon
increas
influenza
viru
iav
coronaviru
respiratori
syncyti
viru
rsv
augment
bacteri
adher
epitheli
cell
iav
also
shown
promot
nasopharyng
colon
pneumonia
virus
also
modifi
host
immun
function
interfer
antibiot
activ
virus
alter
mucou
properti
diminish
normal
mucociliari
clearanc
coat
epitheli
cell
reduc
product
bactericid
substanc
nasopharynx
et
middl
ear
caviti
henc
increas
bacteri
pathogen
mucociliari
chang
et
lead
et
dysfunct
andor
obstruct
neg
middl
ear
pressur
occur
sever
young
children
document
tympanometr
measur
uri
neg
middl
ear
pressur
facilit
entranc
pathogen
bacteria
virus
middl
ear
caviti
caus
middl
ear
inflamm
mef
accumul
sign
symptom
aom
viral
uri
evolv
follow
direct
invas
mucosa
coat
upper
airway
viral
agent
undergo
frequent
chang
antigen
pose
challeng
immun
defens
system
inocul
viru
begin
secret
transfer
touch
hand
expos
pathogen
nose
mouth
directli
inhal
respiratori
droplet
viral
uri
symptom
result
inflammatori
respons
immun
system
invad
pathogen
local
infect
nasopharynx
easili
spread
adjac
organ
lead
sinus
laryng
tracheobronch
pneumonia
aom
particular
sever
respiratori
virus
extens
studi
relat
aom
pathogenesi
among
common
import
iav
rsv
human
rhinoviru
hrv
adenoviru
iav
influenza
viru
respiratori
viru
effect
vaccin
antivir
drug
current
avail
make
possibl
use
influenza
vaccin
andor
antivir
drug
prevent
aom
associ
influenza
onethird
twothird
young
children
influenzaassoci
uri
develop
aom
iav
replic
respiratori
epitheli
cell
circul
leukocyt
produc
chemokin
cytokin
induc
extravas
blood
mononuclear
cell
extravascular
matrix
develop
antivir
immun
respons
iav
secret
neuraminidas
shown
increas
pneumococc
adhes
invas
capabl
et
middl
ear
iavmedi
inflamm
caus
et
congest
reduc
cilial
function
result
bacteri
clearanc
inhibit
earli
viral
challeng
studi
adult
volunt
infect
iav
shown
develop
et
obstruct
neg
middl
ear
pressur
develop
mef
lesser
extent
experiment
model
util
human
middl
ear
epitheli
cell
iav
infect
led
signific
chang
host
interferoninduc
gene
chemokin
cytokin
gene
pro
antiapoptot
gene
signal
transduct
transcript
factor
cellular
immun
respons
cell
cycl
metabol
gene
anim
model
mice
infect
intranas
iav
middl
ear
inflamm
even
hear
loss
document
iav
coinfect
pneumonia
result
higher
bacteri
load
compar
bacteri
infect
alon
rsv
larg
rna
paramyxoviru
commonli
associ
bronchiol
pneumonia
young
children
may
also
caus
acut
respiratori
diseas
includ
uri
age
group
rsv
detect
first
time
mef
date
rsv
consid
one
ototrop
virus
nearli
half
young
children
rsvuri
develop
aom
within
week
uri
onset
mostli
within
week
children
present
aom
rsv
found
specimen
obtain
nasal
wash
mef
sampl
rsv
detect
mef
rang
aom
case
without
posit
bacteri
cultur
also
demonstr
rsv
import
contribut
factor
occurr
aom
young
children
hospit
respiratori
distress
recent
studi
children
age
month
hospit
acut
bronchiol
half
aom
entri
develop
aom
within
day
develop
mef
throughout
observ
period
rsv
identifi
half
mef
aspir
obtain
rsv
also
demonstr
significantli
prime
express
sever
proinflammatori
interleukin
il
import
mediat
fever
acut
phase
respons
requir
resist
pneumonia
hrv
one
common
caus
uri
adult
children
also
strongli
associ
aom
primari
site
inocul
hrv
nasal
mucosa
attach
respiratori
epithelium
spread
local
major
hrv
receptor
intercellular
adhes
natur
respons
human
defens
system
injuri
involv
aid
bind
endotheli
cell
leukocyt
approxim
children
month
age
hrv
present
nasopharyng
secret
develop
aom
within
week
uri
onset
advanc
molecular
biolog
use
nucleic
acid
detect
method
pcr
realtim
pcr
microarray
genom
sequenc
allow
discoveri
hrv
also
made
possibl
studi
serotyp
divers
hrv
infect
hrv
also
detect
mef
one
recent
studi
report
high
hrv
detect
rate
children
histori
recurr
aom
hrv
also
associ
poor
bacteriolog
outcom
aom
treat
antibiot
compar
respiratori
virus
adenoviru
also
common
uri
viru
one
ototrop
virus
nearli
half
children
month
old
adenoviru
uri
develop
aom
within
week
uri
onset
children
infect
adenoviru
time
like
aom
without
perfor
compar
children
respiratori
viru
infect
chinchilla
model
aom
adenoviru
shown
synergist
effect
nontyp
h
influenza
one
debat
adenoviru
uri
aom
develop
fact
adenoviru
nucleic
acid
detect
pcr
sever
month
initi
infect
therefor
detect
adenoviru
nucleic
acid
nasopharyng
secret
may
alway
indic
viru
caus
current
uri
aom
among
children
frequent
uri
kalu
et
al
shown
repeat
posit
pcr
result
adenoviru
may
repres
new
serotypestrain
prolong
presenc
strain
continu
intermitt
detect
symptomat
uri
addit
virus
parainfluenza
virus
type
human
enterovirus
found
associ
aom
approxim
onethird
uri
associ
virus
develop
aom
within
week
uri
onset
mani
type
common
uri
virus
includ
coronavirus
also
report
associ
aom
develop
uri
use
sensit
pcr
techniqu
enabl
detect
rel
new
virus
human
bocaviru
hbov
detect
upper
airway
young
children
respiratori
tract
infect
small
singlestrand
dna
parvoviru
found
alon
often
combin
virus
known
caus
respiratori
symptom
frequent
hbov
coinfect
virus
presenc
respiratori
tract
asymptomat
children
pathogen
role
hbov
question
recent
studi
seroconvers
primari
infect
associ
respiratori
ill
aom
young
children
studi
help
clarifi
signific
role
hbov
dna
detect
nasopharynx
mef
serum
children
aom
sever
studi
hbov
infect
may
worsen
clinic
symptom
prolong
clinic
outcom
aom
addit
concurr
presenc
hbov
h
influenza
nasopharynx
associ
higher
risk
aom
children
first
identifi
role
human
metapneumoviru
hmpv
aom
complic
uri
also
studi
mani
studi
shown
hmpv
preval
infect
almost
children
age
year
caus
respiratori
infect
aom
hmpv
detect
nasopharyng
sampl
mef
sampl
approxim
onequart
hmpvassoci
uri
episod
complic
aom
lowest
rate
compar
respiratori
virus
date
data
anim
model
well
clinic
studi
clearli
shown
viru
caus
uri
compromis
upper
airway
may
lead
aom
even
absenc
pathogen
bacteria
earlier
studi
chinchilla
shown
iav
adenoviru
alon
caus
aom
recent
studi
mice
also
shown
abil
iav
induc
nonbacteri
aom
hear
loss
studi
use
comprehens
microbiolog
diagnost
detect
bacteria
broad
spectrum
virus
mef
children
aom
drain
tympanostomi
tube
ruohola
et
al
report
case
virus
alon
pathogen
bacteria
alon
bacteria
virus
anoth
clinic
studi
aom
develop
uri
episod
report
incid
aom
uri
case
type
pathogen
bacteria
colon
nasopharynx
incid
case
pathogen
bacteria
colon
report
continu
indic
pathogen
role
virus
aom
even
absenc
bacteria
numer
report
interact
context
aom
pathogenesi
mani
review
anim
model
aom
synerg
bacteria
virus
evid
higher
proport
anim
infect
bacteria
viru
develop
aom
infect
bacteria
viru
alon
shown
anim
infect
influenza
adenoviru
andor
pneumonia
adenoviru
andor
nontyp
h
influenza
rsv
also
facilit
bacteri
adhes
epitheli
cell
anim
studi
demonstr
presenc
rsv
nasopharynx
certain
strain
catarrhali
enhanc
abil
adher
epitheli
cell
recent
report
intranas
challeng
chinchilla
catarrhali
follow
rsv
infect
result
subtl
sign
aom
multipl
sign
inflamm
observ
middl
ear
mucosa
vasodilat
submucos
edema
erythema
bullou
myring
follow
sacrific
although
virus
intracellular
microorgan
thu
infect
cell
oppos
colon
cell
surfac
studi
use
pcr
detect
respiratori
virus
nasopharynx
asymptomat
children
studi
associ
respiratori
virus
pathogen
bacteria
asymptomat
aborigin
nonaborigin
children
virus
detect
respect
hrv
frequent
viru
detect
associ
presenc
h
influenza
catarrhali
aborigin
children
adenoviru
posit
correl
h
influenza
aborigin
children
catarrhali
nonaborigin
children
neg
associ
pneumonia
aborigin
children
associ
virus
aom
bacteri
pathogen
may
implic
futur
aom
prevent
strategi
recent
studi
examin
risk
aom
develop
uri
associ
specif
combin
respiratori
virus
aom
bacteri
pathogen
detect
uri
data
prospect
longitudin
studi
includ
children
month
age
uri
microbiolog
studi
includ
nasopharyng
bacteri
viral
cultur
quantit
pcr
rsv
hbov
hmpv
presenc
adenoviru
bocaviru
pneumonia
nontyp
h
influenza
catarrhali
significantli
associ
aom
occurr
high
rsv
viral
load
copiesml
associ
aom
risk
high
viral
load
hbov
hmpv
adjust
presenc
key
virus
bacteria
aom
risk
factor
aom
risk
associ
high
rsv
viral
load
pneumonia
ci
nontyp
h
influenza
ci
risk
higher
presenc
hbov
h
influenza
togeth
ci
author
suggest
aom
prevent
method
consid
method
reduc
infect
caus
rsv
hbov
adenoviru
addit
aom
bacteri
pathogen
aom
commonli
occur
bacteri
complic
viral
uri
time
aom
establish
viral
uri
may
abort
viru
may
never
enter
middl
ear
viru
infect
middl
ear
along
bacteria
viral
uri
still
ongo
time
aom
diagnosi
mani
earlier
studi
shown
interact
lead
advers
aom
outcom
prolong
aom
symptom
bacteriolog
failur
result
concurr
viral
infect
mechan
virusinduc
inflamm
interfer
antibiot
penetr
middl
ear
earlier
studi
detect
virus
convent
diagnost
viral
cultur
antigen
detect
less
sensit
molecular
diagnost
pcr
therefor
detect
virus
case
larger
inoculum
due
widespread
use
pcr
respiratori
viru
detect
nasopharynx
mef
viru
yield
achiev
higher
proport
case
broader
spectrum
virus
howev
debat
still
ongo
whether
detect
viral
nucleic
acid
oppos
live
virus
mef
indic
signific
role
detect
viru
futur
studi
still
requir
confirm
effect
low
quantiti
virus
mef
detect
pcr
clinic
cours
recoveri
aom
knowledg
understand
aom
clinic
implic
aom
manag
known
mani
patient
mild
moder
aom
recov
spontan
without
antibiot
therapi
viral
aom
may
explain
case
categori
initi
observ
watch
wait
becom
accept
option
primari
aom
accord
clinic
practic
guidelin
around
world
hand
aom
pure
bacteri
infect
result
antibiot
treatment
may
expect
respons
antibiot
treatment
case
viral
coinfect
may
partial
although
bacteri
pathogen
sensit
antibiot
use
clinician
may
consid
allow
time
clinic
respons
without
chang
antibiot
case
less
sever
persist
symptom
enorm
data
gather
role
respiratori
virus
pathogen
bacteria
aom
pathogenesi
clear
prevent
aom
achiev
prevent
viral
uri
prevent
elimin
nasopharyng
colon
pathogen
bacteria
specif
earli
treatment
viral
uri
possibl
date
effect
prevent
treatment
respiratori
virus
avail
influenza
trival
inactiv
influenza
vaccin
tiv
live
attenu
influenza
vaccin
laiv
recommend
routin
use
children
age
tiv
laiv
shown
effect
prevent
influenza
influenzaassoci
aom
morbid
recent
report
analyz
data
efficaci
laiv
influenzaassoci
aom
conclud
children
receiv
laiv
high
level
protect
influenzaassoci
aom
compar
placebo
tiv
howev
laiv
current
licens
children
older
year
age
antivir
drug
random
doubleblind
placebocontrol
studi
children
shown
use
oral
oseltamivir
within
h
influenzalik
symptom
reduc
new
aom
diagnosi
subsequ
analys
cohort
show
among
laboratoryconfirm
influenza
case
oseltamivir
significantli
reduc
aom
occurr
rel
risk
ci
treatment
effect
greatest
children
age
year
old
reduct
bacteri
colon
current
avail
bacteri
vaccin
pneumonia
sevenval
pneumococc
conjug
vaccin
becam
avail
routin
administr
infant
unit
state
vaccin
aim
prevent
diseas
caus
common
serotyp
pneumonia
dramat
reduc
incid
penumococc
invas
diseas
children
pneumonia
strain
express
vaccinetyp
serotyp
virtual
disappear
nasopharynx
mef
howev
overal
reduct
aom
case
follow
introduct
current
licens
vaccin
ad
benefit
aim
serotyp
pneumonia
approv
unit
state
sinc
impact
aom
preval
reduct
publish
although
predict
reduct
aom
vaccin
use
one
way
reduc
colon
pathogen
bacteria
augment
interfer
infant
neg
associ
nasopharyng
colon
pneumonia
nontyp
h
influenza
aureu
shown
vitro
studi
shown
inhibit
aom
bacteri
pathogen
bacteri
flora
alphahemolyt
streptococci
therefor
investig
attempt
use
probiot
oral
administr
nasal
spray
prevent
recurr
aom
episod
reduc
middl
ear
effus
date
studi
shown
conflict
result
studi
shown
posit
effect
probiot
reduc
aom
incid
other
shown
posit
outcom
differ
type
probiot
dose
rout
administr
may
partli
explain
differ
result
studi
need
identifi
promis
probiot
benefici
aom
prevent
aom
one
common
infecti
diseas
children
econom
individu
burden
diseas
remark
date
aom
regard
multifactori
polymicrobi
diseas
challeng
research
explor
molecular
genet
immunolog
microbi
metabol
pathway
particip
aom
pathogenesi
interact
play
signific
role
aom
pathogenesi
clinic
implic
knowledg
understand
interact
basi
success
manag
prevent
strategi
common
childhood
diseas
